Cargando…
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer
SKP2, an F-box protein of the SCF type of the E3 ubiquitin ligase complex, plays an important function in driving tumorigenesis through the destruction of numerous tumor-suppressive proteins. Besides its critical role in cell cycle regulation, proto-oncogenic functions of SKP2 have also been shown i...
Autores principales: | Rezaeian, Abdol-Hossein, Phan, Liem Minh, Zhou, Xiaobo, Wei, Wenyi, Inuzuka, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006859/ https://www.ncbi.nlm.nih.gov/pubmed/36871351 http://dx.doi.org/10.1016/j.neo.2023.100890 |
Ejemplares similares
-
ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development
por: Phan, Liem Minh, et al.
Publicado: (2021) -
Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing Twist
por: Ruan, Diane, et al.
Publicado: (2017) -
Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012) -
Identification of acetylation-dependent regulatory mechanisms that govern the oncogenic functions of Skp2
por: Wang, Zhiwei, et al.
Publicado: (2012) -
Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1
por: Gao, Daming, et al.
Publicado: (2009)